Format
Sort by
Items per page

Send to

Choose Destination

Best matches for levosimendan:

Levosimendan meta-analyses: Is there a pattern in the effect on mortality? Pollesello P et al. Int J Cardiol. (2016)

Levosimendan in Cardiac Surgery. Mehta RH et al. N Engl J Med. (2017)

Levosimendan in Cardiac Surgery. Landoni G et al. N Engl J Med. (2017)

Search results

Items: 1 to 20 of 1266

1.

In vitro effects of levosimendan on muscle of malignant hyperthermia susceptible and non-susceptible swine.

Schuster F, Johannsen S, Isbary S, Türkmeneli I, Roewer N.

BMC Anesthesiol. 2018 Dec 3;18(1):182. doi: 10.1186/s12871-018-0644-z.

2.

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper.

Herpain A, Bouchez S, Girardis M, Guarracino F, Knotzer J, Levy B, Liebregts T, Pollesello P, Ricksten SE, Riha H, Rudiger A, Sangalli F.

J Cardiovasc Pharmacol. 2018 Nov 22. doi: 10.1097/FJC.0000000000000636. [Epub ahead of print]

PMID:
30489437
3.

Levosimendan is superior to epinephrine on coronary flow for lipid-base resuscitation of bupivacaine-induced asystole in the isolated rat heart.

Chen H, Xia F, Jin Z, Shi K, Xia Y, Liu L, Papadimos TJ, Xu X, Chen L.

BMC Anesthesiol. 2018 Nov 20;18(1):174. doi: 10.1186/s12871-018-0627-0.

4.

Cardioprotective effect of levosimendan against homocysteine-induced mitochondrial stress and apoptotic cell death in H9C2.

Aminzadeh A, Mehrzadi S.

Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):395-399. doi: 10.1016/j.bbrc.2018.11.049. Epub 2018 Nov 13.

PMID:
30446219
5.

Levosimendan to prevent acute organ dysfunction in sepsis: the LeoPARDS RCT.

Gordon AC, Santhakumaran S, Al-Beidh F, Orme RML, Perkins GD, Singer M, McAuley DF, Mason AJ, Ward JK, O’Dea KP, Felton T, Cross M, Best-Lane J, Lexow J, Campbell A, Ashby D.

Southampton (UK): NIHR Journals Library; 2018 Nov.

6.

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.

Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola VP, Karason K, Kivikko M, von Lewinski D, Oliva F, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C.

Cardiovasc Drugs Ther. 2018 Dec;32(6):617-624. doi: 10.1007/s10557-018-6838-2. Review.

PMID:
30402660
7.

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.

Pölzl G, Allipour Birgani S, Comín-Colet J, Delgado JF, Fedele F, García-Gonzáles MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Vrtovec B, Wikström G, Altenberger J.

ESC Heart Fail. 2018 Oct 30. doi: 10.1002/ehf2.12366. [Epub ahead of print]

PMID:
30378288
8.

Structural Changes Induced by the Binding of the Calcium Desensitizer W7 to Cardiac Troponin.

Cai F, Hwang PM, Sykes BD.

Biochemistry. 2018 Nov 20;57(46):6461-6469. doi: 10.1021/acs.biochem.8b00882. Epub 2018 Nov 6.

PMID:
30376637
9.

Postoperative management of patients undergoing cardiac surgery in Austria : A national survey on current clinical practice in hemodynamic monitoring and postoperative management.

Menger J, Edlinger-Stanger M, Dworschak M, Steinlechner B.

Wien Klin Wochenschr. 2018 Oct 29. doi: 10.1007/s00508-018-1403-3. [Epub ahead of print]

PMID:
30374775
10.

Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.

Lannemyr L, Ricksten SE, Rundqvist B, Andersson B, Bartfay SE, Ljungman C, Dahlberg P, Bergh N, Hjalmarsson C, Gilljam T, Bollano E, Karason K.

J Am Heart Assoc. 2018 Aug 21;7(16):e008455. doi: 10.1161/JAHA.117.008455.

11.

Levosimendan in Patients with Low Cardiac Output Syndrome Undergoing Cardiac Surgery: a systematic review and meta-analysis.

Zhu J, Zhang Y, Chen L, He Y, Qing X.

Anaesth Crit Care Pain Med. 2018 Oct 17. pii: S2352-5568(18)30171-1. doi: 10.1016/j.accpm.2018.08.005. [Epub ahead of print]

PMID:
30342103
12.

Treatments targeting inotropy.

Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A.

Eur Heart J. 2018 Oct 8. doi: 10.1093/eurheartj/ehy600. [Epub ahead of print]

PMID:
30295807
13.

Short-term effects of levosimendan on strain/strain rate markers in patients with nonischemic dilated cardiomyopathy.

Kırış T, Avcı E.

J Clin Ultrasound. 2018 Oct;46(8):527-532. doi: 10.1002/jcu.22627. Epub 2018 Sep 19.

PMID:
30229927
14.

Levosimendan use in patients with preoperative low ejection fraction undergoing cardiac surgery: A systematic review with meta-analysis and trial sequential analysis.

Ng KT, Chan XL, Tan W, Wang CY.

J Clin Anesth. 2019 Feb;52:37-47. doi: 10.1016/j.jclinane.2018.08.019. Epub 2018 Aug 30. Review.

PMID:
30172838
15.

Levosimendan for Pediatric Anomalous Left Coronary Artery From the Pulmonary Artery Undergoing Repair: A Single-Center Experience.

Wang C, Gong J, Shi S, Wang J, Gao Y, Wang S, Peng YG, Song J, Wang Y.

Front Pediatr. 2018 Aug 14;6:225. doi: 10.3389/fped.2018.00225. eCollection 2018.

16.

Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration.

Oliva F, Perna E, Marini M, Nassiacos D, Cirò A, Malfatto G, Morandi F, Caico I, Perna G, Meloni S, Vincenzi A, Villani A, Vecchi AL, Minoia C, Verde A, De Maria R; RELEVANT-HF study group.

Int J Cardiol. 2018 Dec 1;272:255-259. doi: 10.1016/j.ijcard.2018.08.048. Epub 2018 Aug 16.

PMID:
30131229
17.

Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass.

Poidinger B, Kotzinger O, Rützler K, Kleinsasser A, Zierer A, Knotzer H.

J Cardiothorac Vasc Anesth. 2018 Aug 16. pii: S1053-0770(18)30514-7. doi: 10.1053/j.jvca.2018.07.013. [Epub ahead of print]

PMID:
30122612
18.

Preconditioning by Levosimendan is Mediated by Activation of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels.

Bunte S, Behmenburg F, Bongartz A, Stroethoff M, Raupach A, Heinen A, Minol JP, Hollmann MW, Huhn R, Sixt SU.

Cardiovasc Drugs Ther. 2018 Oct;32(5):427-434. doi: 10.1007/s10557-018-6819-5.

PMID:
30120617
19.

Manipulating the Microcirculation in Sepsis - the Impact of Vasoactive Medications on Microcirculatory Blood Flow. A Systematic Review.

Potter EK, Hodgson L, Creagh-Brown B, Forni LG.

Shock. 2018 Aug 10. doi: 10.1097/SHK.0000000000001239. [Epub ahead of print]

PMID:
30102639
20.

The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study.

Kundra TS, Prabhakar V, Kaur P, Manjunatha N, Gandham R.

J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2123-2129. doi: 10.1053/j.jvca.2018.04.022. Epub 2018 Apr 6.

PMID:
30098861

Supplemental Content

Loading ...
Support Center